# Specification Quality Checklist: Complete Wound Materialization and Healing

**Purpose**: Validate specification completeness and quality before proceeding to planning

**Created**: 2026-08-26

**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No `[NEEDS CLARIFICATION]` markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- 2026-09-26 C4-GM-TRANSPORT: appended a proposed bounded GM response contract
  to spec.md after inspecting the actual file/worker and C2 routes. Purpose,
  closed envelopes, phase-specific permissions, preserved original authority,
  stale/repeated delivery and both transport acceptance paths are explicit.
  Independent Astra XHigh identified missing durable choice binding before
  dependent repair. Revision2 now specifies pendingSubmission in the existing
  checkpoint, strict allocation-prefix replay, the automatic guarantee branch,
  atomic advance/clear and the post-apply ready race check. Targeted re-review
  found no remaining actionable issue. Revision1 is superseded; user approval
  was explicitly granted for revision2 on2026-09-26. Contract details here are intentional GM
  interface requirements. Detailed plan/tasks and their pre-implementation
  consistency check precede dependent implementation. C4-A
  verification and already-approved output/restart investigation remain separate.
- The mandatory verification section names repository commands because project governance requires executable verification evidence; product requirements and success criteria remain technology-agnostic.
- The specification deliberately defines universal mechanical primitives without defining a catalog of complete wounds, symptoms, medicines, or cures.
- The user's section-by-section design approval and advance approval of the written specification resolve all product-level choices before the formal clarification pass.
- Revalidated 2026-08-29 after the T064 authority review: all seven Mortal occurrence kinds now require signed causal authority, complete-event-set parity, explicit create/worsen semantics, and durable decision replay; no new product clarification is required.
- Revalidated 2026-09-08 after the user's source-envelope clarification: ordinary actions have no extra source cap; special declarations must pre-exist the harmful event and obey all harder limits. US3 scenarios and FR-032 agree with both spiritual contracts, research, data model, plan, and tasks. All 16 checks remain satisfied; executable declaration design and implementation remain open in T081-B2C-J2-B.
- 2026-09-19 C2-PREFIX clarification: requested result, preserved contracts, direct/triggered changes, receipt/missing-side retries, rejection cases and internal-only scope are explicit. Earlier approval notes above do not approve this new written version. Owner review is pending; exact implementation API, canonical plan/tasks update and pre-implementation consistency analysis remain future work. Existing task T081-B2C-J2-C2-PREFIX remains unchecked.
- 2026-09-19 follow-up: the owner explicitly approved the C2-PREFIX written version. Canonical plan/tasks and scoped consistency pass now cover P1 and dependency-gated P2/P3; implementation acceptance remains open.
- 2026-09-22 T081-C durable boundary: the owner explicitly approved the separate pending/receipt
  roots, cold reconstruction, sole common publication, rollback and exact replay contract. The
  canonical research, data model, quickstart, five-unit execution plan and task decomposition are
  aligned; T081-D and T081-E retain their existing consequence/source-family ownership, and the
  separate recovery/force-incarnation cost decision remains unresolved and out of scope.

## RESULT-CLOSURE-BINDING review — 2026-09-29

- [x] Requested result, terminal-only scope and preserved existing contracts are explicit.
- [x] Ordinary exchange rules, exact carrier/presence, separate Ready and cold replay are specified.
- [x] Independently proved existing cost permissions and stronger force-binding prerequisites remain intact.
- [x] Acceptance names the mixed-cost, boolean-only strong-setup and unrelated-root-error regressions.
- [x] Independent Astra XHigh design review closed both contract findings; its three requested acceptance cases are recorded.
- [x] Owner explicitly approved this exact written revision1 (spec65BDA9AB) on2026-09-29.
- [ ] Canonical implementation plan/tasks and scoped consistency check are ready before dependent implementation.

This checklist does not mark production implementation or the parent RESULT-CLOSURE task complete.
